CVE:KHRN Khiron Life Sciences (KHRN) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free KHRN Stock Alerts C$0.04 0.00 (0.00%) (As of 05/5/2023) Add Compare Share Share Today's RangeC$0.04▼C$0.0550-Day RangeC$0.04▼C$0.0452-Week RangeC$0.04▼C$0.21Volume24,000 shsAverage Volume256,268 shsMarket CapitalizationC$9.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Khiron Life Sciences alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Khiron Life Sciences Stock (CVE:KHRN)Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Read More KHRN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KHRN Stock News HeadlinesDecember 21, 2023 | msn.comFocus: Colombia's cannabis industry in crisis over regulatory, political hurdlesNovember 17, 2023 | benzinga.comGlobal Cannabis Co. Trading Lower On Announcing Amended European Business Sale DealApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.November 16, 2023 | finance.yahoo.comKhiron Life Sciences Announces Update to the Proposed Sale of Its European BusinessMay 24, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)May 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Monday (KHRN)May 4, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)April 26, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Tuesday (KHRN)April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 25, 2023 | msn.comCannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & MoreApril 25, 2023 | finance.yahoo.comMedical First: Germany Strengthens Reimbursement of Medical CannabisApril 22, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Friday (KHRN-WT)April 21, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp up on Thursday (KHRN)April 21, 2023 | msn.comKhiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS SubsidiaryApril 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Tuesday (KHRN-WT)April 15, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp flat on Friday (KHRN)April 14, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Wednesday (KHRN)April 14, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Thursday (KHRN-WT)April 7, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Wednesday (KHRN-WT)April 4, 2023 | finance.yahoo.comKhiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment OptionMarch 27, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES SIZING OF MARKETED OFFERING OF UNITSMarch 13, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT MARKETED OFFERINGFebruary 11, 2023 | theglobeandmail.comKhiron Life Sciences: Stocks Overvalued by Analyst Consensus on TSX-V (KHRN)January 19, 2023 | ca.finance.yahoo.comKhiron begins dispensation of insurance-covered prescriptions in ColombiaJanuary 19, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron begins dispensation of insurance-covered prescriptions in ColombiaJanuary 16, 2023 | benzinga.comNHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patientJanuary 16, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: NHS reimburses the cost of cannabis treatment to the first Zerenia Clinics UK patientSee More Headlines Receive KHRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:KHRN CUSIPN/A CIKN/A Webwww.khiron.ca Phone705-527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-30,660,000.00 Net Margins-190.00% Pretax MarginN/A Return on Equity-74.68% Return on Assets-20.79% Debt Debt-to-Equity Ratio9.46 Current Ratio2.02 Quick Ratio0.72 Sales & Book Value Annual SalesC$16.14 million Price / Sales0.58 Cash FlowC$0.01 per share Price / Cash Flow6.67 Book ValueC$0.12 per share Price / Book0.33Miscellaneous Outstanding Shares232,410,000Free FloatN/AMarket CapC$9.30 million OptionableNot Optionable Beta2.64 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Alvaro Francisco Torres (Age 45)Co-Founder, CEO & Director Comp: $272.95kMs. Franziska KatterbachPresident of Khiron EuropeMr. Swapan Kakumanu ACA (Age 54)ACWA, CGA, Corporate Secretary Comp: $60kMr. Michael John O'Connor MA (Age 57)Chief Financial Officer Mr. Manuel BuendiaVice President of OperationsMr. Marco AlgortaCountry Manager of UruguayMore ExecutivesKey CompetitorsCrescita TherapeuticsTSE:CTXMedicureCVE:MPHValeo PharmaTSE:VPHAleafia HealthTSE:AHFlowrCVE:FLWRView All Competitors KHRN Stock Analysis - Frequently Asked Questions How have KHRN shares performed in 2024? Khiron Life Sciences' stock was trading at C$0.04 at the start of the year. Since then, KHRN stock has increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here. What other stocks do shareholders of Khiron Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Walt Disney (DIS), Energy Transfer (ET), KushCo (KSHB), Neptune Wellness Solutions (NEPT), Organigram (OGI) and VIVO Cannabis (VVCIF). How do I buy shares of Khiron Life Sciences? Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:KHRN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
